Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: Results of a randomised double blind placebo controlled study
- 30 April 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 94 (2-3) , 235-240
- https://doi.org/10.1016/j.ijcard.2003.04.009
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Coronary Risk Factor Management for the Prevention and Treatment of Graft Vessel Disease in Heart Transplant PatientsTherapeutic Apheresis, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Task force 5: ComplicationsJournal of the American College of Cardiology, 1993
- RISK FACTOR ANALYSIS FOR THE MAJOR HAZARDS FOLLOWING HEART TRANSPLANTATION—REJECTION, INFECTION, AND CORONARY OCCLUSIVE DISEASETransplantation, 1991
- Lovastatin therapy for hypercholesterolemia in cardiac transplant recipientsThe American Journal of Cardiology, 1989
- Retransplantation for severe accelerated coronary artery disease in heart transplant recipientsThe American Journal of Cardiology, 1988
- Rhabdomyolysis and Renal Injury With Lovastatin UsePublished by American Medical Association (AMA) ,1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988